Every open market buy and sale of OnKure Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $6K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when OKUR insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an OKUR officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every OKUR insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Nicholas A SaccomanoPresident and CEO | Sale | 87 | $2.97 | $259 | 11,160 | Sep 23Form 4 |
| Sep 21, 2026 | Jason A. LeveroneCFO | Sale | 302 | $2.97 | $898 | 18,500 | Sep 23Form 4 |
| Jun 22, 2026 | Nicholas A SaccomanoPresident and CEO | Sale | 86 | $4.40 | $378 | 11,247 | Jun 24Form 4 |
| Jun 22, 2026 | Jason A. LeveroneCFO | Sale | 303 | $4.40 | $1K | 18,802 | Jun 24Form 4 |
| Mar 23, 2026 | Nicholas A SaccomanoPresident and CEO | Sale | 86 | $4.16 | $358 | 7,333 | Mar 24Form 4 |
| Mar 23, 2026 | Jason A. LeveroneCFO | Sale | 301 | $4.16 | $1K | 16,000 | Mar 24Form 4 |
| Dec 22, 2025 | Nicholas A SaccomanoPresident and CEO | Sale | 87 | $2.97 | $258 | 7,419 | Dec 23Form 4 |
| Dec 22, 2025 | Jason A. LeveroneCFO | Sale | 302 | $2.97 | $897 | 16,301 | Dec 23Form 4 |
| Sep 22, 2025 | Nicholas A SaccomanoPresident and CEO | Sale | 88 | $2.62 | $231 | 3,506 | Sep 24Form 4 |
| Sep 22, 2025 | Jason A. LeveroneCFO | Sale | 303 | $2.62 | $794 | 12,603 | Sep 24Form 4 |
| Jun 23, 2025 | Jason A. LeveroneCFO | Sale | 303 | $2.38 | $721 | 12,906 | Jun 25Form 4 |
| Jun 23, 2025 | Nicholas A SaccomanoPresident and CEO | Sale | 88 | $2.38 | $209 | 3,594 | Jun 25Form 4 |
| May 15, 2025 | Acorn Capital Advisors Gp, LLC10% owner | Buy | 1,400,000 | $1.85 | $2.6M | 1,129,730 | May 19Form 4 |
| May 15, 2025 | Cormorant Private Healthcare Fund III LPInsider | Sale | 1,813,439 | $1.85 | $3.4M | 0 | May 19Form 4 |
| May 12, 2025 | Cormorant Global Healthcare Master Fund, LP10% owner | Sale | 24,300 | $1.99 | $48K | 1,813,439 | May 14Form 4 |
OKUR insider trading FAQ
Are OKUR insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of OKUR on the open market in 0 trades, and 2 sold $6K in 8 trades.
When did an OKUR insider last buy shares?
Acorn Capital Advisors Gp, LLC (10% owner) bought 1,400,000 shares for $2.6M on May 15, 2025, reported on May 19, 2025.
When did an OKUR insider last sell shares?
Nicholas A Saccomano (President and CEO) sold 87 shares for $259 on Sep 21, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
